Do analysts rate SMRT or NCTY?

SmartRent currently has a consensus price target of $1.20, suggesting a potential downside of 16.38%. Given SmartRent's stronger consensus rating and higher probable upside, analysts plainly believe SmartRent is more favorable than The9. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SmartRent 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 The9 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, SMRT or NCTY?

The9 has lower revenue, but higher earnings than SmartRent. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SmartRent $152.33M 1.81 -$60.56M -$0.10 N/A The9 $83.78M 0.80 -$57.55M N/A N/A

Is SMRT or NCTY more profitable?

The9 has a net margin of 0.00% compared to SmartRent's net margin of -12.97%. The9's return on equity of 0.00% beat SmartRent's return on equity. Company Net Margins Return on Equity Return on Assets SmartRent -12.97% -8.50% -6.27% The9 N/A N/A N/A

Does the media favor SMRT or NCTY?

In the previous week, The9 had 2 more articles in the media than SmartRent. MarketBeat recorded 7 mentions for The9 and 5 mentions for SmartRent. SmartRent's average media sentiment score of 1.75 beat The9's score of 0.49 indicating that SmartRent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SmartRent 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive The9 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer DMAA or NCTY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Drugs Made In America Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 The9 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, DMAA or NCTY?

Drugs Made In America Acquisition has higher earnings, but lower revenue than The9. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Drugs Made In America Acquisition N/A N/A N/A N/A N/A The9 $83.78M 0.80 -$57.55M N/A N/A

Is DMAA or NCTY more profitable?

Company Net Margins Return on Equity Return on Assets Drugs Made In America Acquisition N/A N/A N/A The9 N/A N/A N/A

Does the media favor DMAA or NCTY?

In the previous week, The9 had 6 more articles in the media than Drugs Made In America Acquisition. MarketBeat recorded 7 mentions for The9 and 1 mentions for Drugs Made In America Acquisition. The9's average media sentiment score of 0.49 beat Drugs Made In America Acquisition's score of 0.00 indicating that The9 is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Drugs Made In America Acquisition 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral The9 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate NCTY or DVLT?

Datavault AI has a consensus target price of $2.50, suggesting a potential upside of 688.64%. Given Datavault AI's stronger consensus rating and higher possible upside, analysts clearly believe Datavault AI is more favorable than The9. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The9 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Datavault AI 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has better earnings and valuation, NCTY or DVLT?

The9 has higher revenue and earnings than Datavault AI. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The9 $83.78M 0.80 -$57.55M N/A N/A Datavault AI $39.09M 7.70 -$78.99M -$0.92 N/A

Is NCTY or DVLT more profitable?

The9 has a net margin of 0.00% compared to Datavault AI's net margin of -370.21%. The9's return on equity of 0.00% beat Datavault AI's return on equity. Company Net Margins Return on Equity Return on Assets The9 N/A N/A N/A Datavault AI -370.21% -46.04% -39.35%

Does the media prefer NCTY or DVLT?

In the previous week, Datavault AI had 26 more articles in the media than The9. MarketBeat recorded 33 mentions for Datavault AI and 7 mentions for The9. The9's average media sentiment score of 0.49 beat Datavault AI's score of 0.10 indicating that The9 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The9 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Datavault AI 9 Very Positive mention(s) 0 Positive mention(s) 19 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral

Do analysts prefer KLTR or NCTY?

Kaltura currently has a consensus price target of $3.00, suggesting a potential upside of 90.48%. Given Kaltura's stronger consensus rating and higher probable upside, equities analysts plainly believe Kaltura is more favorable than The9. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kaltura 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 The9 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, KLTR or NCTY?

Kaltura has higher revenue and earnings than The9. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kaltura $180.85M 1.33 -$12.07M -$0.09 N/A The9 $83.78M 0.80 -$57.55M N/A N/A

Is KLTR or NCTY more profitable?

The9 has a net margin of 0.00% compared to Kaltura's net margin of -6.92%. The9's return on equity of 0.00% beat Kaltura's return on equity. Company Net Margins Return on Equity Return on Assets Kaltura -6.92% -51.05% -2.33% The9 N/A N/A N/A

Does the media favor KLTR or NCTY?

In the previous week, The9 had 6 more articles in the media than Kaltura. MarketBeat recorded 7 mentions for The9 and 1 mentions for Kaltura. Kaltura's average media sentiment score of 1.79 beat The9's score of 0.49 indicating that Kaltura is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kaltura 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive The9 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend BGIN or NCTY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bgin Blockchain 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 The9 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, BGIN or NCTY?

The9 has higher revenue and earnings than Bgin Blockchain. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bgin Blockchain $67.40M 3.40 -$176.86M N/A N/A The9 $83.78M 0.80 -$57.55M N/A N/A

Is BGIN or NCTY more profitable?

Company Net Margins Return on Equity Return on Assets Bgin Blockchain N/A N/A N/A The9 N/A N/A N/A

The9 (NCTY) Competitors

$4.38 -1.20 (-21.45%)

As of 12:45 PM Eastern

Compare

NCTY vs. SMRT, DMAA, DVLT, KLTR, and BGIN

Should you buy The9 stock or one of its competitors? The9's main competitors and comparable companies include SmartRent (SMRT), Drugs Made In America Acquisition (DMAA), Datavault AI (DVLT), Kaltura (KLTR), and Bgin Blockchain (BGIN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does The9 compare to SmartRent?

SmartRent (NYSE:SMRT) and The9 (NASDAQ:NCTY) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, The9 had 2 more articles in the media than SmartRent. MarketBeat recorded 7 mentions for The9 and 5 mentions for SmartRent. SmartRent's average media sentiment score of 1.75 beat The9's score of 0.49 indicating that SmartRent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SmartRent	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
The9	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

The9 has lower revenue, but higher earnings than SmartRent.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SmartRent	$152.33M	1.81	-$60.56M	-$0.10	N/A
The9	$83.78M	0.80	-$57.55M	N/A	N/A

SmartRent currently has a consensus price target of $1.20, suggesting a potential downside of 16.38%. Given SmartRent's stronger consensus rating and higher probable upside, analysts plainly believe SmartRent is more favorable than The9.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SmartRent	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
The9	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

SmartRent has a beta of 1.52, indicating that its stock price is 52% more volatile than the broader market. Comparatively, The9 has a beta of 2.15, indicating that its stock price is 115% more volatile than the broader market.

The9 has a net margin of 0.00% compared to SmartRent's net margin of -12.97%. The9's return on equity of 0.00% beat SmartRent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SmartRent	-12.97%	-8.50%	-6.27%
The9	N/A	N/A	N/A

59.4% of SmartRent shares are owned by institutional investors. Comparatively, 0.5% of The9 shares are owned by institutional investors. 2.3% of SmartRent shares are owned by company insiders. Comparatively, 30.8% of The9 shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

The9 beats SmartRent on 7 of the 13 factors compared between the two stocks.

How does The9 compare to Drugs Made In America Acquisition?

Drugs Made In America Acquisition (NASDAQ:DMAA) and The9 (NASDAQ:NCTY) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Drugs Made In America Acquisition has a beta of 0.01, meaning that its share price is 99% less volatile than the broader market. Comparatively, The9 has a beta of 2.15, meaning that its share price is 115% more volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
Drugs Made In America Acquisition	N/A	N/A	N/A
The9	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Drugs Made In America Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
The9	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, The9 had 6 more articles in the media than Drugs Made In America Acquisition. MarketBeat recorded 7 mentions for The9 and 1 mentions for Drugs Made In America Acquisition. The9's average media sentiment score of 0.49 beat Drugs Made In America Acquisition's score of 0.00 indicating that The9 is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Drugs Made In America Acquisition	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
The9	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Drugs Made In America Acquisition has higher earnings, but lower revenue than The9.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Drugs Made In America Acquisition	N/A	N/A	N/A	N/A	N/A
The9	$83.78M	0.80	-$57.55M	N/A	N/A

0.5% of The9 shares are owned by institutional investors. 0.9% of Drugs Made In America Acquisition shares are owned by insiders. Comparatively, 30.8% of The9 shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

The9 beats Drugs Made In America Acquisition on 6 of the 6 factors compared between the two stocks.

How does The9 compare to Datavault AI?

The9 (NASDAQ:NCTY) and Datavault AI (NASDAQ:DVLT) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment.

In the previous week, Datavault AI had 26 more articles in the media than The9. MarketBeat recorded 33 mentions for Datavault AI and 7 mentions for The9. The9's average media sentiment score of 0.49 beat Datavault AI's score of 0.10 indicating that The9 is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The9	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Datavault AI	9 Very Positive mention(s)	0 Positive mention(s)	19 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

The9 has a beta of 2.15, indicating that its share price is 115% more volatile than the broader market. Comparatively, Datavault AI has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market.

Datavault AI has a consensus target price of $2.50, suggesting a potential upside of 688.64%. Given Datavault AI's stronger consensus rating and higher possible upside, analysts clearly believe Datavault AI is more favorable than The9.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The9	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Datavault AI	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

0.5% of The9 shares are owned by institutional investors. Comparatively, 0.7% of Datavault AI shares are owned by institutional investors. 30.8% of The9 shares are owned by company insiders. Comparatively, 7.7% of Datavault AI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

The9 has higher revenue and earnings than Datavault AI.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The9	$83.78M	0.80	-$57.55M	N/A	N/A
Datavault AI	$39.09M	7.70	-$78.99M	-$0.92	N/A

The9 has a net margin of 0.00% compared to Datavault AI's net margin of -370.21%. The9's return on equity of 0.00% beat Datavault AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The9	N/A	N/A	N/A
Datavault AI	-370.21%	-46.04%	-39.35%

Summary

The9 beats Datavault AI on 8 of the 15 factors compared between the two stocks.

How does The9 compare to Kaltura?

Kaltura (NASDAQ:KLTR) and The9 (NASDAQ:NCTY) are both small-cap technology companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

Kaltura has higher revenue and earnings than The9.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kaltura	$180.85M	1.33	-$12.07M	-$0.09	N/A
The9	$83.78M	0.80	-$57.55M	N/A	N/A

Kaltura currently has a consensus price target of $3.00, suggesting a potential upside of 90.48%. Given Kaltura's stronger consensus rating and higher probable upside, equities analysts plainly believe Kaltura is more favorable than The9.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kaltura	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
The9	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

30.8% of Kaltura shares are held by institutional investors. Comparatively, 0.5% of The9 shares are held by institutional investors. 16.3% of Kaltura shares are held by company insiders. Comparatively, 30.8% of The9 shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

The9 has a net margin of 0.00% compared to Kaltura's net margin of -6.92%. The9's return on equity of 0.00% beat Kaltura's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kaltura	-6.92%	-51.05%	-2.33%
The9	N/A	N/A	N/A

In the previous week, The9 had 6 more articles in the media than Kaltura. MarketBeat recorded 7 mentions for The9 and 1 mentions for Kaltura. Kaltura's average media sentiment score of 1.79 beat The9's score of 0.49 indicating that Kaltura is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kaltura	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
The9	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Kaltura has a beta of 1.15, indicating that its stock price is 15% more volatile than the broader market. Comparatively, The9 has a beta of 2.15, indicating that its stock price is 115% more volatile than the broader market.

Summary

Kaltura beats The9 on 8 of the 14 factors compared between the two stocks.

How does The9 compare to Bgin Blockchain?

Bgin Blockchain (NASDAQ:BGIN) and The9 (NASDAQ:NCTY) are both small-cap technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bgin Blockchain	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
The9	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, The9 had 7 more articles in the media than Bgin Blockchain. MarketBeat recorded 7 mentions for The9 and 0 mentions for Bgin Blockchain. The9's average media sentiment score of 0.49 beat Bgin Blockchain's score of 0.00 indicating that The9 is being referred to more favorably in the news media.

Company	Overall Sentiment
Bgin Blockchain	Neutral
The9	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Bgin Blockchain	N/A	N/A	N/A
The9	N/A	N/A	N/A

0.5% of The9 shares are held by institutional investors. 30.8% of The9 shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

The9 has higher revenue and earnings than Bgin Blockchain.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bgin Blockchain	$67.40M	3.40	-$176.86M	N/A	N/A
The9	$83.78M	0.80	-$57.55M	N/A	N/A

Summary

The9 beats Bgin Blockchain on 6 of the 7 factors compared between the two stocks.

Get The9 News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NCTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NCTY vs. The Competition

Export

Metric	The9	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$66.66M	$15.49B	$29.00B	$12.76B
Dividend Yield	N/A	3.42%	2.74%	10.78%
P/E Ratio	N/A	126.49	72.33	24.20
Price / Sales	0.80	1,283.84	591.13	128.00
Price / Cash	N/A	45.05	49.03	36.89
Price / Book	2.73	8.52	7.90	6.52
Net Income	-$57.55M	$434.52M	$678.06M	$347.63M
7 Day Performance	1.27%	2.92%	0.19%	1.57%
1 Month Performance	36.29%	6.89%	4.20%	5.22%
1 Year Performance	-47.35%	5.47%	188.54%	17.83%

The9 Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NCTY The9	0.5606 of 5 stars	$4.38 -21.5%	N/A	-34.1%	$66.66M	$83.78M	N/A	70	News Coverage Gap Down
SMRT SmartRent	2.041 of 5 stars	$1.39 -0.4%	$1.20 -13.4%	-4.7%	$265.38M	$152.33M	N/A	640	Positive News
DMAA Drugs Made In America Acquisition	0.5257 of 5 stars	$10.72 0.0%	N/A	+4.6%	$260.16M	N/A	N/A	2	News Coverage
DVLT Datavault AI	3.647 of 5 stars	$0.30 -22.9%	$2.50 +738.9%	-25.1%	$254.63M	$39.09M	N/A	40	Trending News Analyst Revision High Trading Volume
KLTR Kaltura	3.0193 of 5 stars	$1.67 -0.3%	$3.00 +80.2%	+9.4%	$254.00M	$180.85M	N/A	680

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NCTY) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The9 (NCTY) Competitors